Zinc Sulfate in the Treatment of Rosacea: A Randomized, Controlled Trial
Stopped early · Not applicable · Has a placebo group
Conditions studied: Rosacea
In brief
Rosacea is a common chronic dermatological condition, characterized by recurrent or persistent redness, permanent dilation of small blood vessel causing small red lesions, and papules/pustules. The signs of rosacea are usually confined to the face, but may appear on the neck, scalp or trunk. Opthalmologic findings are also common. Rosacea is usually described as being most common in fair skinned women over 40. The purpose of the study is to determine whether oral Zinc Sulfate treatment is an effective treatment for facial rosacea.
Key facts
- Study ID
- NCT00395226
- Run by
- Essentia Health
- People needed
- 65
- Starts
- 2006-07-01
- Expected to finish
- 2008-07-01
- Last updated by the study team
- 2011-06-30
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Diagnosis of facial rosacea made or confirmed by one of the investigators.
- Severity of signs of rosacea "greater than mild" at the time of enrollment.
You may not qualify if…
- Treatment for rosacea during the 3 months prior to enrollment.
- Use of zinc dietary supplement > 25 mg per day during the 3 months prior to enrollment ( Most patients taking multivitamins with Zinc, often 15 mg per day, will not be excluded, whereas most patients taking additional Zinc supplements, often 25-50 mg per day or more will be excluded.)
- Diagnosis of rosacea fulminancy.
- Pregnant or breast feeding.
Where it is running
- St. Mary's Duluth Clinic Health System — Duluth, Minnesota, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.